Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

The latest clinical guidelines from the American College of Gastroenterology aim to improve the diagnosis and treatment of ...

Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory disease of undetermined pathophysiology that results in dense mucosal eosinophilia and esophageal dysfunction. In childhood ...

The association between early childhood serum 25-hydroxyvitamin D (25(OH)D) and eosinophilic asthma remains unclear. We ...

Compared with female patients, male patients with eosinophilic esophagitis have higher rates of complications, including ...

Are you stuck in a cycle of asthma attacks? You may have eosinophilic asthma. Find out what it is and what you can do to break the cycle.

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease (COPD), according to a study published online Nov. 27 in The ...

Asthma is a chronic lung disease that causes ... the FDA granted it orphan drug designation for the treatment of eosinophilic esophagitis. The medication targets a type of white blood cell known ...

Discover top medications for 'treating Eosinophilic Esophagitis (EoE)'? This page compiles essential information on generic and brand-name drugs specifically used for Eosinophilic Esophagitis (EoE ...

The total market size of eosinophilic esophagitis in 2023 was approximately USD 1.80 trillion in the 7MM, which is expected to grow during the forecast period (2020-2034). Among EU4 and the UK, ...